SCHEMBL1721764

SCHEMBL1721764

COc1ccc(C(Sc2ccc(-c3cccc(N)n3)cc2)c2ccc(OC)cc2)cc1.COc1ccc(C(c2ccc(OC)cc2)c2csc(B(O)O)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
DYRK1A Q13627 1/20 0.33
LTA4H P09960 2/20 0.33
ATP4A P20648 2/20 0.32
ATP4B P51164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
MPO P05164 1/20 0.32
SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1721763 0.84 ENPP2 (0.40) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL2033015 0.83 ASIC3 (0.43) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1684447 0.76 SLC2A1 (0.44) MAPTALDH1A1CYP1A2KDM4E
SCHEMBL1723482 0.70 ALDH1A1 (0.43) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL8090460 0.69 ASIC3 (0.60) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1684444 0.65 CA2 (0.61) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL2558010 0.62 NPC1 (0.46) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL14457583 0.60 CA1 (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL1684377 0.60 SERPINH1 (0.43) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3628069 0.60 NPC1 (0.61) MAPTALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2395002-B1 PHARMACEUTICAL COMPOSITION CONTAINING A HETEROCYCLIC MODULATOR OF ATP-BINDING CASSETTE TRANSPORTERS. VERTEX PHARMA (US) 2014-06-18 EP disclosed
EP-2404919-B1 Heterocyclic compound useful as a modulator of ATP-binding cassette transporters. VERTEX PHARMA (US) 2013-08-21 EP disclosed
EP-2404919-A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters. Vertex Pharmaceuticals Incorporated (US) 2012-01-11 EP disclosed